Product References
miR-27b-3p Attenuates Muscle Atrophy by Targeting Cbl-b in Skeletal Muscles.
Biomolecules
Yang X,Li Z,Wang Z,Yu J,Ma M,Nie Q
Sun Jan 23 00:00:00 EST 2022
Cbl-b modulated TrkA ubiquitination and function in the dorsal root ganglion of mice.
European journal of pharmacology
Chen HK,Li YZ,Ge AN,Zhu YB,Wu SJ,Bai X,Bai HH,Liu YN
Fri Apr 15 00:00:00 EDT 2022
Cbl-b modulated TrkA ubiquitination and function in the dorsal root ganglion of mice.
European journal of pharmacology
Chen HK,Li YZ,Ge AN,Zhu YB,Wu SJ,Bai X,Bai HH,Liu YN
Fri Apr 15 00:00:00 EDT 2022
Mechanism of Yangxinshi Intervention on Cardiac Fibrosis in Diabetic Cardiomyopathy Based on Network Pharmacology.
Evidence-based complementary and alternative medicine : eCAM
Kuang J,Wu K,Li W,Zhang X,Zhang H,Jia Z,Han Q,Tian X,Sun R,Lu Q,Liu Y
Sat Apr 30 00:00:00 EDT 2022
Ionic Liquid-Based Extraction System for In-Depth Analysis of Membrane Protein Complexes.
Analytical chemistry
Chu H,Zhao Q,Liu J,Yang K,Wang Y,Liu J,Zhang K,Zhao B,He H,Zheng Y,Zhong S,Liang Z,Zhang L,Zhang Y
Tue Jan 18 00:00:00 EST 2022
Targeting the Cbl-b-Notch1 axis as a novel immunotherapeutic strategy to boost CD8+ T-cell responses.
Frontiers in immunology
Monticone G,Huang Z,Csibi F,Leit S,Ciccone D,Champhekar AS,Austin JE,Ucar DA,Hossain F,Ibba SV,Boulares AH,Carpino N,Xu K,Majumder S,Osborne BA,Loh C,Miele L
Tue Sep 13 00:00:00 EDT 2022
Targeting the Cbl-b-Notch1 axis as a novel immunotherapeutic strategy to boost CD8+ T-cell responses.
Frontiers in immunology
Monticone G,Huang Z,Csibi F,Leit S,Ciccone D,Champhekar AS,Austin JE,Ucar DA,Hossain F,Ibba SV,Boulares AH,Carpino N,Xu K,Majumder S,Osborne BA,Loh C,Miele L
Tue Sep 13 00:00:00 EDT 2022
Targeting the Cbl-b-Notch1 axis as a novel immunotherapeutic strategy to boost CD8+ T-cell responses.
Frontiers in immunology
Monticone G,Huang Z,Csibi F,Leit S,Ciccone D,Champhekar AS,Austin JE,Ucar DA,Hossain F,Ibba SV,Boulares AH,Carpino N,Xu K,Majumder S,Osborne BA,Loh C,Miele L
Tue Sep 13 00:00:00 EDT 2022
Targeting the Cbl-b-Notch1 axis as a novel immunotherapeutic strategy to boost CD8+ T-cell responses.
Frontiers in immunology
Monticone G,Huang Z,Csibi F,Leit S,Ciccone D,Champhekar AS,Austin JE,Ucar DA,Hossain F,Ibba SV,Boulares AH,Carpino N,Xu K,Majumder S,Osborne BA,Loh C,Miele L
Tue Sep 13 00:00:00 EDT 2022
Cbl-b deficiency prevents functional but not phenotypic T cell anergy.
The Journal of experimental medicine
Nguyen TTT,Wang ZE,Shen L,Schroeder A,Eckalbar W,Weiss A
Mon Jul 05 00:00:00 EDT 2021
Effects of Atypical Protein Kinase C Inhibitor (DNDA) on Lung Cancer Proliferation and Migration by PKC-ι/FAK Ubiquitination Through the Cbl-b Pathway.
OncoTargets and therapy
BommaReddy RR,Patel R,Smalley T,Acevedo-Duncan M
Wed Apr 13 00:00:00 EDT 2022
Effects of Atypical Protein Kinase C Inhibitor (DNDA) on Lung Cancer Proliferation and Migration by PKC-ι/FAK Ubiquitination Through the Cbl-b Pathway.
OncoTargets and therapy
BommaReddy RR,Patel R,Smalley T,Acevedo-Duncan M
Wed Apr 13 00:00:00 EDT 2022
Ubiquitination and functional modification of GluN2B subunit-containing NMDA receptors by Cbl-b in the spinal cord dorsal horn.
Science signaling
Zhang ZY,Bai HH,Guo Z,Li HL,Diao XT,Zhang TY,Yao L,Ma JJ,Cao Z,Li YX,Bai X,Chen HK,Suo ZW,Yang X,Hu XD
Tue Jun 30 00:00:00 EDT 2020
Bta-miR-223 Targeting CBLB Contributes to Resistance to Staphylococcus aureus Mastitis Through the PI3K/AKT/NF-κB Pathway.
Frontiers in veterinary science
Han S,Li X,Liu J,Zou Z,Luo L,Wu R,Zhao Z,Wang C,Shen B
Tue Nov 17 00:00:00 EST 2020
Cbl Proto-Oncogene B (CBLB) c.197A>T Mutation Induces Mild Metabolic Dysfunction in Partial Type I Multiple Symmetric Lipomatosis (MSL).
Diabetes, metabolic syndrome and obesity : targets and therapy
Chen K,Wan X,Zhao L,Zhao S,Peng L,Yang W,Yuan J,Zhu L,Mo Z
Sun Apr 17 00:00:00 EDT 2022
Cbl Proto-Oncogene B (CBLB) c.197A>T Mutation Induces Mild Metabolic Dysfunction in Partial Type I Multiple Symmetric Lipomatosis (MSL).
Diabetes, metabolic syndrome and obesity : targets and therapy
Chen K,Wan X,Zhao L,Zhao S,Peng L,Yang W,Yuan J,Zhu L,Mo Z
Sun Apr 17 00:00:00 EDT 2022
NR4A1 counteracts JNK activation incurred by ER stress or ROS in pancreatic β-cells for protection.
Journal of cellular and molecular medicine
Pu ZQ,Liu D,Lobo Mouguegue HPP,Jin CW,Sadiq E,Qin DD,Yu TF,Zong C,Chen JC,Zhao RX,Lin JY,Cheng J,Yu X,Li X,Zhang YC,Liu YT,Guan QB,Wang XD
Tue Dec 01 00:00:00 EST 2020
NR4A1 counteracts JNK activation incurred by ER stress or ROS in pancreatic β-cells for protection.
Journal of cellular and molecular medicine
Pu ZQ,Liu D,Lobo Mouguegue HPP,Jin CW,Sadiq E,Qin DD,Yu TF,Zong C,Chen JC,Zhao RX,Lin JY,Cheng J,Yu X,Li X,Zhang YC,Liu YT,Guan QB,Wang XD
Tue Dec 01 00:00:00 EST 2020
A multiple sclerosis-associated variant of CBLB links genetic risk with type I IFN function.
Journal of immunology (Baltimore, Md. : 1950)
Stürner KH,Borgmeyer U,Schulze C,Pless O,Martin R
Sat Nov 01 00:00:00 EDT 2014
A multiple sclerosis-associated variant of CBLB links genetic risk with type I IFN function.
Journal of immunology (Baltimore, Md. : 1950)
Stürner KH,Borgmeyer U,Schulze C,Pless O,Martin R
Sat Nov 01 00:00:00 EDT 2014